GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » YoY EPS Growth

Zentek (TSXV:ZEN) YoY EPS Growth : 33.33% (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zentek YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Zentek's YoY EPS Growth for the quarter that ended in Dec. 2024 was 33.33%.

Zentek's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was C$-0.02.

Zentek YoY EPS Growth Historical Data

The historical data trend for Zentek's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek YoY EPS Growth Chart

Zentek Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.00 -150.00 -580.00 58.82 14.29

Zentek Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -50.00 - - 33.33

Zentek YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Zentek's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-0.12--0.14)/ | -0.14 |
=14.29 %

Zentek's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(-0.02--0.03)/ | -0.03 |
=33.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentek YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Zentek's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentek Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » YoY EPS Growth
Comparable Companies
TSXV:OTC XCNQ:DTR ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM BAX COO WST XTER:SRT HOLX SOLV ALGN NZSE:FPH
Traded in Other Exchanges
ZTEK:USA ZAY:Germany
Address
24 Corporate Court, Guelph, ON, CAN, N1G 5G5
Website
https://www.zentek.com
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Executives
Colin Stuart Van Der Kuur Senior Officer
Francis Jacques Dubé Director
Ilse Treurnicht Director
John Snisarenko Director
Brian Gerald Bosse Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Gregory Fenton Director
Eric Wallman Director